These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8881845)
1. Felodipine in addition to beta-adrenergic blockade for angina pectoris. a multicentre, randomized, placebo-controlled trial. Rønnevik PK; Silke B; Ostergaard O Eur Heart J; 1995 Nov; 16(11):1535-41. PubMed ID: 8881845 [TBL] [Abstract][Full Text] [Related]
2. Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group. Emanuelsson H; Egstrup K; Nikus K; Ellström J; Glud T; Pater C; Scheibel M; Tisell A; Tötterman KJ; Forsby M Am Heart J; 1999 May; 137(5):854-62. PubMed ID: 10220634 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy]. Mazzotta G; Falcidieno M; Ravera E; Vecchio C G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025 [TBL] [Abstract][Full Text] [Related]
4. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade. Results of the Felodipine ER and Metoprolol CR in Angina (FEMINA) Study. Working Group on Cardiovascular Research, The Netherlands (WCN). Dunselman P; Liem AH; Verdel G; Kragten H; Bosma A; Bernink P Eur Heart J; 1997 Nov; 18(11):1755-64. PubMed ID: 9402450 [TBL] [Abstract][Full Text] [Related]
5. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris. de Vries RJ; Dunselman PH; van Veldhuisen DJ; van den Heuvel AF; Wielenga RP; Lie KI Am J Cardiol; 1994 Dec; 74(12):1201-6. PubMed ID: 7977090 [TBL] [Abstract][Full Text] [Related]
7. Adding the new calcium antagonist mibefradil to patients receiving long-term beta-blocker therapy results in improved antianginal and antiischemic efficacy. Schneeweiss A; Kobrin I; Charlon V; Caspi A; Marmor A; Sclarovsky S; Reisin L; Schlesinger Z Am Heart J; 1998 Feb; 135(2 Pt 1):272-80. PubMed ID: 9489976 [TBL] [Abstract][Full Text] [Related]
8. Felodipine versus placebo in stable effort-induced angina pectoris in patients inadequately controlled with metoprolol--a dose-finding study. Emanuelsson H; Ahlström P; Kujacic V; Lundkvist L; Rosenqvist U; Tisell A; Angman K J Cardiovasc Pharmacol; 1994 Aug; 24(2):303-9. PubMed ID: 7526065 [TBL] [Abstract][Full Text] [Related]
9. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy. Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710 [TBL] [Abstract][Full Text] [Related]
10. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial. Koenig W; Höher M J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363 [TBL] [Abstract][Full Text] [Related]
11. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Alpert JS; Kobrin I; DeQuattro V; Friedman R; Shepherd A; Fenster PE; Thadani U Am J Cardiol; 1997 Apr; 79(8):1025-30. PubMed ID: 9114758 [TBL] [Abstract][Full Text] [Related]
12. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. Dunselman PH; van Kempen LH; Bouwens LH; Holwerda KJ; Herweijer AH; Bernink PJ Am J Cardiol; 1998 Jan; 81(2):128-32. PubMed ID: 9591892 [TBL] [Abstract][Full Text] [Related]
13. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
14. 24 h anti-anginal and anti-ischaemic effects with once daily felodipine. A double-blind comparison with nifedipine, twice daily, and placebo in patients with stable exercise induced angina pectoris. Schulte KL Eur Heart J; 1995 Feb; 16(2):171-6. PubMed ID: 7744087 [TBL] [Abstract][Full Text] [Related]
15. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris. Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874 [TBL] [Abstract][Full Text] [Related]
16. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. Sheridan JV; Thomas P; Routledge PA; Sheridan DJ Br J Clin Pharmacol; 1987 Apr; 23(4):391-6. PubMed ID: 3107605 [TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris. Santoro G; Savonitto S; Di Bello V; Alberti D; Giusti C Am J Cardiol; 1991 Aug; 68(5):457-62. PubMed ID: 1872271 [TBL] [Abstract][Full Text] [Related]
18. The effects of felodipine in angina pectoris. Lorimer AR; MacFarlane P; Pringle S; Barbour MP; Fox Y; Lawrie TD Eur J Clin Pharmacol; 1990; 38(5):415-9. PubMed ID: 2116311 [TBL] [Abstract][Full Text] [Related]
20. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]